Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
52.4M
-
Number of holders
-
109
-
Total 13F shares, excl. options
-
29.5M
-
Shares change
-
+12.8M
-
Total reported value, excl. options
-
$503M
-
Value change
-
+$214M
-
Put/Call ratio
-
0
-
Number of buys
-
59
-
Number of sells
-
-46
-
Price
-
$17.06
Significant Holders of 2seventy bio, Inc. - Common Stock (TSVT) as of Q1 2022
134 filings reported holding TSVT - 2seventy bio, Inc. - Common Stock as of Q1 2022.
2seventy bio, Inc. - Common Stock (TSVT) has 109 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.5M shares
of 52.4M outstanding shares and own 56.26% of the company stock.
Largest 10 shareholders include EcoR1 Capital, LLC (3.5M shares), STATE STREET CORP (3.16M shares), WELLINGTON MANAGEMENT GROUP LLP (2.51M shares), BAKER BROS. ADVISORS LP (2.06M shares), ARMISTICE CAPITAL, LLC (2M shares), Newtyn Management, LLC (1.59M shares), Bain Capital Life Sciences Investors, LLC (1.41M shares), VANGUARD GROUP INC (1.38M shares), RTW INVESTMENTS, LP (1.23M shares), and CREDIT SUISSE AG/ (1M shares).
This table shows the top 109 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.